510(k) Report

510(k) · Cleared

Cleared

Uni-Gold Cryptosporidium

K121565510(k) TraditionalCleared Feb 8, 2013255-day reviewClass II21 CFR 866.3220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Trinity Biotech · MHJ Cryptosporidium Spp.

Cleared on Feb 8, 2013 as substantially equivalent to K031965 (Remel, Inc., 2003) after a 255-day review. Its family tree reaches back 2 generations to 1999.

Decided
Feb 8, 2013
Review
255 days
Class
Class II
Product code
MHJ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K983399 (1999). No later device cites it as a predicate yet.

  1. Root · 2 generations backK983399 Giardia/Cryptosporidium Combo Rapid AssayGenzyme Diagnostics · 1999 · Recalled
  2. 1 generation backK031965 Xpect Cryptosporidium Lateral Flow Assay, Model 2451020Remel, Inc. · 2003 · Recalled
  3. This deviceK121565 Uni-Gold CryptosporidiumTrinity Biotech · 2013
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K983399Giardia/Cryptosporidium Combo Rapid AssayGenzyme Diagnostics19992
−1K031965Xpect Cryptosporidium Lateral Flow Assay, Model 2451020Remel, Inc.20031
0 (this device)K121565Uni-Gold CryptosporidiumTrinity Biotech2013—
FIG. 1 — Lineage of K121565, 1999–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MHJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K031965Xpect Cryptosporidium Lateral Flow Assay, Model 2451020
Summary page 2
…Page: 2 of 8 YOUR PARTNER DIAGNOSTICS Predicate Remel Xpect Cryptosporidium (51OK #: K031 965) Device Device Description The Trinity Biotech Uni-God T MI Cryptosporidium Test was designed as a single…
Remel, Inc.20031

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 9.2 years on median.
  • 2 of the 2 ancestors have a recall of any class.

How does its category compare?

All MHJ devices

MHJ Cryptosporidium Spp.: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · MHJ

1in 2017

2013: 12017: 1
2007high 1 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MHJ

Too few MHJ 510(k)s in any year since 2007 to give a median.

Recalls per year · MHJ

No recall names MHJ since 2007.

Adverse event reports per year · MHJ

No MAUDE report names MHJ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20131—00
20140—00
20150—00
20160—00
20171—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Trinity Biotech Uni-GoldTM Cryptosporidium is a single use rapid immunoassay for the qualitative detection of Cryptosporidium parvum (C parvum) antigens in human stool specimens. This test is intended for use with patients with gastrointestinal symptoms as an aid in the diagnosis of suspected Cryptosporidium gastrointestinal infections. As with other Cryptosporidium tests, results should be considered in conjunction with the clinical evaluation and medical history. For In-Vitro Diagnostic use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K121565: Uni-Gold Cryptosporidium.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K121565

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026